Baudax Bio Inc. (BXRX) Fundamentals

Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings.
SHARE INFORMATION
Market Cap$ 5,073,982
Shares Outstanding6,422,762
Float6,365,779
Percent Float99.11%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,080,000
Latest Fiscal EPS$ -10.85
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions53
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months319,940
Institutional Holdings Percent22.4%
Institutional Sold Previous 3 Months149,680
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months252,305
Insider Holdings Percent10.4
Insider Sold Previous 3 Months-
Insider Shares Owned667,719
TRADING INFO
52 Week High$ 26.60
52 Week Low$ 0.67
52 Week High Change$ -95.93
21 Day Moving Average$ 0.7502
21 Day Extended Moving Average$ 0.757319
50 Day Moving Average$ 0.7675
50 Day Extended Moving Average$ 0.907851
200 Day Moving Average$ 5.4691
200 Day Extended Moving Average$ 7.7103
10 Day Average Volume181,161
20 Day Average Volume132,382
30 Day Average Volume124,318
50 Day Average Volume140,103
Alpha-0.128466
Beta1.5262
Standard Deviation0.263574
R20.114874
7 Day Price Change$ 0.0719
7 Day Percent Change10.01%
21 Day Price Change$ 0.05
21 Day Percent Change6.76%
30 Day Price Change$ -0.0825
30 Day Percent Change-9.46%
Month to Date Price Change$ 0.0873
Month to Date Percent Change12.42%
Quarter to Date Price Change$ -0.055
Quarter to Date Percent Change-6.51%
180 Day Price Change$ -6.07
180 Day Percent Change-88.48%
200 Day Price Change$ -6.04
200 Day Percent Change-88.42%
Year to Date Price Change$ -6.88
Year to Date Percent Change-89.7%

Baudax Bio Inc. (BXRX) Key Ratios

PROFITABILITY
EBIT Margin-1,484.4%
EBITDA Margin-1,271.7%
Pre-Tax Profit Margin0.0%
Profit Margin Count-30.55%
Gross Margin-74.2%
Profit Margin TOT-30.55%
INCOME STATEMENTS
Revenue$ 1,103,000
Revenue Per Share$ 0.1717
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.40
Total Debt To Equity0.90
Int Coverage-26.10
Current Ratio1.00
Leverage Ratio4.40
Quick Ratio0.60
Long Term Debt To Capital0.37
VALUATION MEASURES
PE Ratio-0.20
Enterprise Value$ 2,115,299
Price to Sales4.6002
Price to Free Cash-0.10
PE High Last 5 Years0.00
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book-0.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.10
Invoice Turnover0.50
Assets Turnover0.00
Return Assets-29.22
Return on Equity-413.49
Return on Capital-134.53

Baudax Bio Inc. (BXRX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG LLP
CEOGerri A. Henwood
Emplyoees80
Last AuditUE
CIK0001780097
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address490 Lapp Road
Malvern, PA 19355
Websitehttps://www.baudaxbio.com
Facsimile+1 484 395-2471
Telephone+1 484 395-2470
Email-


Your Recent History
NASDAQ
BXRX
Baudax Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.